These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association between maternal Gm allotype and neonatal septicaemia with group B streptococci. Grubb R; Christensen KK; Christensen P; Lindén V J Immunogenet; 1982 Apr; 9(2):143-7. PubMed ID: 7045234 [TBL] [Abstract][Full Text] [Related]
23. Opsonization of Salmonella enteritidis lipopolysaccharide in sickle cell disease. Field RJ; Overturf GD; Strunk R Pediatr Res; 1981 Feb; 15(2):107-11. PubMed ID: 7019833 [No Abstract] [Full Text] [Related]
24. Intravenous immunoglobulin with high activity against group B streptococci. Gloser H; Bachmayer H; Helm A Pediatr Infect Dis; 1986; 5(3 Suppl):S176-9. PubMed ID: 3520502 [No Abstract] [Full Text] [Related]
25. Group B streptococcus in neonatal infection: identification of the mother at high-risk of fetal colonization. Deiter RW J Am Osteopath Assoc; 1983 Mar; 82(7):498-504. PubMed ID: 6341332 [No Abstract] [Full Text] [Related]
27. Possible contribution of the complement system to the inflammatory state. Hadding U Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199 [No Abstract] [Full Text] [Related]
28. [The complement system as a mediator of acute inflammation]. Müller-Peddinghaus R Dtsch Tierarztl Wochenschr; 1983 Sep; 90(9):374-7. PubMed ID: 6354683 [No Abstract] [Full Text] [Related]
29. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. Hirsch RL; Winkelstein JA; Griffin DE J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263 [No Abstract] [Full Text] [Related]
30. [Immunologic characteristics of neonates with sepsis]. Isakov IuF; Samsygin SA; Dolgina EN Vestn Akad Med Nauk SSSR; 1981; (12):7-12. PubMed ID: 7331495 [No Abstract] [Full Text] [Related]
31. [B-streptococcus infections. Pathogenicity of B-streptococci (Streptococcus agalactiae) in the perinatal and neonatal period. Diagnosis and therapy]. Niesen M; Müller HE; Schneider J Fortschr Med; 1973 Sep; 91(25):986-92. PubMed ID: 4585194 [No Abstract] [Full Text] [Related]
32. [Neonatal factors influencing infections and their severity in newborn infants]. Burdea M Rev Med Chir Soc Med Nat Iasi; 1980; 84(1):143-5. PubMed ID: 6967224 [No Abstract] [Full Text] [Related]
33. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. Butko P; Nicholson-Weller A; Wessels MR J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019 [TBL] [Abstract][Full Text] [Related]
35. [Hope of a vaccine against neonatal GBS infection]. Källman J; Schollin J; Kihlström E Lakartidningen; 1995 Jul; 92(30-31):2819-24. PubMed ID: 7643690 [No Abstract] [Full Text] [Related]
36. Bactericidal activity elicited by the beta C protein of group B streptococci contrasted with capsular polysaccharides. Fusco PC; Perry JW; Liang SM; Blake MS; Michon F; Tai JY Adv Exp Med Biol; 1997; 418():841-5. PubMed ID: 9331784 [No Abstract] [Full Text] [Related]
37. [Recent progress and clinical significance of complement system]. Okada H Ryumachi; 1992 Dec; 32(6):550-3. PubMed ID: 1296333 [No Abstract] [Full Text] [Related]
38. Group B streptococcal infections. Baker CJ Adv Intern Med; 1980; 25():475-501. PubMed ID: 6153860 [No Abstract] [Full Text] [Related]
39. [Function of complement system and its role in biodefense]. Morita Y; Matsuo S; Okada N Nihon Rinsho; 2005 Jul; 63 Suppl 7():41-6. PubMed ID: 16111184 [No Abstract] [Full Text] [Related]